The heart in Anderson-Fabry disease and other lysosomal storage disordersLINHART, Ales; ELLIOTT, Perry M.Heart (London 1996). 2007, Vol 93, Num 4, pp 528-535, issn 1355-6037, 8 p.Article

Treatment of Takotsubo Cardiomyopathy : News in therapy of cardiomyopathyPALECEK, Tomas; KUCHYNKA, Petr; LINHART, Ales et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 26, pp 2905-2909, issn 1381-6128, 5 p.Article

Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12- to 36-Month, Retrospective, Blinded Echocardiographic Pooled AnalysisKAMPMANN, Christoph; LINHART, Aleš; DEVEREUX, Richard B et al.Clinical therapeutics. 2009, Vol 31, Num 9, pp 1966-1976, issn 0149-2918, 11 p.Article

Cardiomyopathies métaboliques d'origine génétique = Inherited metabolic cardiomyopathiesGERMAIN, Dominique P; LINHART, Ales; DESNOS, Michel et al.La Presse médicale (1983). 2007, Vol 36, issn 0755-4982, 1S48-1S54, HS1Conference Paper

Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseWHITE, Harvey D; HELD, Claes; ARMSTRONG, Paul W et al.The New England journal of medicine. 2014, Vol 370, Num 18, pp 1702-1711, issn 0028-4793, 10 p.Article

Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry RegistryPATEL, Manesh R; CECCHI, Franco; BEITNER-JOHNSON, Dana et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 9, pp 1093-1099, issn 0735-1097, 7 p.Article

Cardiac manifestations of Anderson-Fabry disease : results from the international fabry outcome surveyLINHART, Ales; KAMPMANN, Christoph; ZAMORANO, José L et al.European heart journal. 2007, Vol 28, Num 10, pp 1228-1235, issn 0195-668X, 8 p.Article

Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathyPALECEK, Tomas; KUCHYNKA, Petr; HULINSKA, Dagmar et al.Medical microbiology and immunology. 2010, Vol 199, Num 2, pp 139-143, issn 0300-8584, 5 p.Article

Onset and progression of the Anderson-Fabry disease related cardiomyopathyKAMPMANN, Christoph; LINHART, Ales; BAEHNER, Frank et al.International journal of cardiology. 2008, Vol 130, Num 3, pp 367-373, issn 0167-5273, 7 p.Article

Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS)PALECEK, Tomas; HONZIKOVA, Jitka; POUPETOVA, Helena et al.Journal of inherited metabolic disease. 2014, Vol 37, Num 3, pp 455-460, issn 0141-8955, 6 p.Article

Association between cardiac energy metabolism and gain of left ventricular mass in Fabry diseasePALECEK, Tomas; BULTAS, Jan; HAJEK, Milan et al.International journal of cardiology. 2010, Vol 144, Num 2, pp 337-339, issn 0167-5273, 3 p.Article

Cardiac and vascular hypertrophy in fabry disease : Evidence for a new mechanism independent of blood pressure and glycosphingolipid depositionBARBEY, Frederic; BRAKCH, Noureddine; HAYOZ, Daniel et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 4, pp 839-844, issn 1079-5642, 6 p.Article

Prevalence of uncontrolled hypertension in patients with fabry diseaseKLEINERT, Julia; DEHOUT, Francois; HOUGE, Gunnar et al.American journal of hypertension. 2006, Vol 19, Num 8, pp 782-787, issn 0895-7061, 6 p.Article

Aortic remodelling in Fabry diseaseBARBEY, Frédéric; QANADLI, Salah D; JULI, Christoph et al.European heart journal. 2010, Vol 31, Num 3, pp 347-353, issn 0195-668X, 7 p.Article